Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type‐5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model
Sign Up to like & getrecommendations! Published in 2020 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.24333
Abstract: To evaluate the impacts of hydrogen sulfide (H2S) donor, sodium hydrogen sulfide (NaHS), and phosphodiesterase type‐5 inhibitor (PDE5i), tadalafil per se and their combination treatment on partial bladder outlet obstruction (PBOO)‐induced erectile dysfunction (ED). read more here.
Keywords: phosphodiesterase type; hydrogen; sodium hydrogen; type inhibitor ... See more keywords
Growth and characterization of an efficient semi organic single crystal: Sodium hydrogen oxalate monohydrate
Sign Up to like & getrecommendations! Published in 2018 at "Chinese Journal of Physics"
DOI: 10.1016/j.cjph.2018.09.038
Abstract: Abstract A highly proficient nonlinear optical compound Sodium Hydrogen Oxalate Monohydrate (SHOM) single crystal under semi organic category has been grown-up by the process of slow solvent evaporation. The triclinic structure and cell parameters of… read more here.
Keywords: hydrogen oxalate; semi organic; single crystal; sodium hydrogen ... See more keywords
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability
Sign Up to like & getrecommendations! Published in 2018 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.aam6474
Abstract: Tenapanor inhibits sodium/hydrogen exchanger isoform 3 to reduce intestinal phosphate absorption via reduction of passive paracellular phosphate flux. Phosphate in flux Kidney failure can decrease the excretion of phosphate, leading to elevated phosphate in the… read more here.
Keywords: hydrogen exchanger; sodium; sodium hydrogen; tenapanor ... See more keywords